Centiva Capital LP Has $986,000 Holdings in Solventum Co. (NYSE:SOLV)

Centiva Capital LP grew its stake in shares of Solventum Co. (NYSE:SOLV) by 32.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,142 shares of the company’s stock after buying an additional 3,434 shares during the quarter. Centiva Capital LP’s holdings in Solventum were worth $986,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Paloma Partners Management Co bought a new position in shares of Solventum during the third quarter worth about $951,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Solventum during the third quarter valued at about $730,000. True Wealth Design LLC increased its holdings in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after purchasing an additional 471 shares in the last quarter. Verition Fund Management LLC bought a new stake in Solventum during the third quarter worth $1,106,000. Finally, HBK Investments L P purchased a new stake in shares of Solventum in the third quarter valued at about $12,823,000.

Analysts Set New Price Targets

A number of research firms recently issued reports on SOLV. Stifel Nicolaus started coverage on shares of Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective for the company. Mizuho began coverage on shares of Solventum in a research note on Wednesday. They set a “neutral” rating and a $70.00 price objective for the company. Piper Sandler raised their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. BTIG Research assumed coverage on shares of Solventum in a report on Thursday, September 5th. They set a “neutral” rating for the company. Finally, Wolfe Research assumed coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $68.29.

Solventum Stock Down 1.0 %

NYSE:SOLV opened at $69.56 on Friday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05. The stock has a fifty day simple moving average of $70.65 and a 200-day simple moving average of $62.82. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.